LGT Group Foundation’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$906K Buy
1,710
+188
+12% +$86.8K 0.01% 202
2026
Q1
$731K Buy
1,522
+38
+3% +$19.5K 0.01% 211
2025
Q4
$844K Sell
1,484
-101
-6% -$57.3K 0.01% 209
2025
Q3
$862K Sell
1,585
-516
-25% -$225K 0.01% 210
2025
Q2
$659K Sell
2,101
-136
-6% -$40.8K 0.01% 219
2025
Q1
$682K Buy
+2,237
New +$752K 0.01% 212

Other funds holding MEDP

LGT Group Foundation's MEDP Position: Q2 2026 in Review

LGT Group Foundation increased its Medpace (MEDP) stake by 12% in Q2 2026, buying an estimated $86.8K and bringing the position to 1,710 shares worth $906K. The position accounts for 0.01% of the portfolio, ranked #202.

LGT Group Foundation first reported a position in MEDP in Q1 2025 and has held it in 6 quarters since. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • LGT Group Foundation held 1,710 shares of Medpace worth $906K as of Q2 2026.
  • LGT Group Foundation bought 188 Medpace shares in Q2 2026, an estimated $86.8K.
  • Medpace made up 0.01% of LGT Group Foundation's portfolio in Q2 2026, its #202 holding.
  • LGT Group Foundation first reported a position in Medpace in Q1 2025 and has held it in 6 quarters since.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on LGT Group Foundation's 13F filing for Q2 2026, filed 10 Aug 2026.